Risk of Malignant Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 01 2019
Historique:
pubmed: 13 11 2018
medline: 15 10 2019
entrez: 13 11 2018
Statut: ppublish

Résumé

The risk of malignant ovarian cancer associated with simple cysts is unknown. To quantify the risk of ovarian cancer based on ultrasonographic characteristics of ovarian masses, including simple cysts, in a large unselected population. This was a nested case-control study of patients enrolled in Kaiser Permanente Washington, a large integrated health care system in Washington State. Participants were 72 093 women who underwent pelvic ultrasonography between January 1, 1997, and December 31, 2008. Analysis was completed in April 2017. Ultrasonographic characteristics of ovarian masses measured in 1043 women, and also, using weights derived from the sampling strategy, estimated frequencies for the entire cohort. Malignant ovarian cancer, identified through December 31, 2011, by cancer registry linkage. Among 210 women who were diagnosed as having ovarian cancer, 49 were younger than 50 years, and 161 were 50 years or older. Ultrasonography findings were predictive of cancer (C statistic, 0.89). The risk of cancer was significantly elevated in women with complex cysts or solid masses, with likelihood ratios relative to women with normal ovaries ranging from 8 to 74 and the 3-year risk of cancer ranging from 9 to 430 cases per 1000 women based on patient age and ultrasonography findings. In contrast, the 23.8% of women younger than 50 years and the 13.4% of women 50 years or older with simple cysts were not at a significantly increased risk of ovarian cancer compared with women with normal ovaries. Likelihood ratios associated with the detection of a simple cyst were 0.00 in women younger than 50 years (no cancers were identified) and 0.10 (95% CI, 0.01-0.48) in women 50 years or older, and the absolute 3-year risk of cancer ranged from 0 to 0.5 cases per 1000 women. According to this study, the ultrasonographic appearance of ovarian masses is strongly associated with a woman's risk of ovarian cancer. Simple cysts are not associated with an increased risk of ovarian cancer, whereas complex cysts or solid masses are associated with a significantly increased risk of ovarian cancer.

Identifiants

pubmed: 30419104
pii: 2714301
doi: 10.1001/jamainternmed.2018.5113
pmc: PMC6583394
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-77

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Am J Obstet Gynecol. 2010 Apr;202(4):373.e1-9
pubmed: 20096820
BMJ. 2014 Oct 15;349:g5920
pubmed: 25320247
Am J Obstet Gynecol. 2015 Nov;213(5):657-61, 657.e1
pubmed: 26116103
J Natl Cancer Inst. 2004 Dec 15;96(24):1840-50
pubmed: 15601640
Cancer Causes Control. 2008 Jun;19(5):515-25
pubmed: 18270798
J Clin Ultrasound. 2013 Jun;41(5):269-74
pubmed: 23504994
Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7
pubmed: 23969786
JAMA. 2012 Jun 13;307(22):2400-9
pubmed: 22692172
Ultrasound Obstet Gynecol. 2012 Sep;40(3):338-44
pubmed: 22911637
Arch Intern Med. 2010 May 10;170(9):749-50
pubmed: 20458080
Hum Reprod Update. 2014 May-Jun;20(3):449-62
pubmed: 24327552
Obstet Gynecol. 2003 Sep;102(3):594-9
pubmed: 12962948
Ultrasound Obstet Gynecol. 2010 Aug;36(2):226-34
pubmed: 20455203
Ultrasound Obstet Gynecol. 2013 May;41(5):570-81
pubmed: 22915541
Obstet Gynecol. 2016 Nov;128(5):e210-e226
pubmed: 27776072
Ultrasound Obstet Gynecol. 2013 Jan;41(1):80-9
pubmed: 23001924
J Ultrasound Med. 2017 May;36(5):849-863
pubmed: 28266033
Radiology. 2010 Sep;256(3):943-54
pubmed: 20505067
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S42-6
pubmed: 7835810
Obstet Gynecol. 2003 Sep;102(3):589-93
pubmed: 12962947
BMJ. 2012 May 28;344:e3502
pubmed: 22645185
Obstet Gynecol. 2016 May;127(5):848-58
pubmed: 27054927
Clin Obstet Gynecol. 2006 Sep;49(3):506-16
pubmed: 16885657
Am J Obstet Gynecol. 2001 Jan;184(2):48-54
pubmed: 11174478

Auteurs

Rebecca Smith-Bindman (R)

Department of Radiology and Biomedical Imaging, University of California, San Francisco.
Department of Epidemiology and Biostatistics, University of California, San Francisco.
Philip Lee Institute for Health Policy Studies, University of California, San Francisco.
Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco.

Liina Poder (L)

Department of Radiology and Biomedical Imaging, University of California, San Francisco.

Eric Johnson (E)

Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle.

Diana L Miglioretti (DL)

Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle.
Department of Public Health Sciences, University of California, Davis.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH